• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Advanced Biomed Inc. (ADVB)
	Q4-CY2026	Q3-CY2026	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014
Balance Sheet Date			2026-Jun-30	2026-Mar-31	2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31
Fiscal Period			Q4-FY2026	Q3-FY2026	Q2-FY2026	Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025
Total Assets			13,750,716$	10,646,324$	10,850,712$	6,242,970$	22,862,095$	8,287,598$	4,504,152$		4,460,247$
Total Current Assets			13,749,512$	10,526,309$	10,731,565$	5,844,133$	22,382,323$	7,731,148$	3,138,891$		3,051,110$
Cash and Cash Equivalents
Receivables
Other Current Assets
Assets Held for Sale in Short Term							4,163,727$
Total Noncurrent Assets			1,204$	120,015$	119,147$	398,837$	479,772$	556,450$	1,365,261$		1,409,137$
Goodwill
Other Intangible Assets								20,325$	50,516$		118,998$
Physical Assets				87,280$	97,100$	281,270$	125,184$	355,274$	401,007$		524,528$
Other Noncurrent Assets				2,184$	956$	74,770$	2,605$
Assets Held for Sale in Long Term							479,772$
Total Liabilities			1,473,989$	1,436,587$	1,369,070$	3,238,846$	19,384,531$	4,157,815$	3,885,120$		2,796,989$
Total Current Liabilities			1,473,989$	1,425,684$	1,253,574$	3,044,952$	19,238,880$	4,113,343$	3,828,794$		2,732,460$
Accounts Payable				377,264$	369,293$	641,587$	358,243$	618,520$	617,865$		620,476$
Short Term Debt
Short Term Capital Lease Obligations				18,608$	19,661$	27,934$	35,811$	138,357$	233,701$		62,211$
Other Current Liabilities			1,078,215$
Total Noncurrent Liabilities			0$	10,903$	115,496$	193,894$	145,651$	44,472$	56,326$		64,529$
Long Term Debt
Long Term Capital Lease Obligations				10,903$	1,431$	2,935$	5,879$	44,472$	56,326$		64,529$
Other Noncurrent Liabilities
Total Equity			12,276,727$	9,209,737$	9,481,642$	3,004,124$	3,477,564$	4,129,783$	619,032$	1,093,830$	1,663,258$	(497,797$)	196,841$
Equity to Minority
Equity to Common Shareholders			12,276,727$	9,209,737$	9,481,642$	3,004,124$	3,477,564$	4,129,783$	619,032$	1,093,830$	1,663,258$	(497,797$)	196,841$
Additional Paid-In Capital
Retained Earnings			(12,555,967$)	(13,250,966$)	(12,762,024$)	(19,619,945$)	(19,233,044$)	(18,531,433$)	(17,147,559$)		(15,974,075$)
Treasury Stock
Capital Lease Obligations				29,511$	21,092$	30,869$	41,690$	182,829$	290,027$		126,740$

Copy Table ✓